higher forecast high convict pick
remain buy rate increas price target
follow anoth solid quarter thesi predic increas
adopt cgm technolog convers larg type diabet
opportun near term view compani
continu deliv consensu sale growth emerg
profit result continu momentum like last quarter
think there potenti upsid guidanc
sales/ep beat sensor revenu stronger model
drove top-lin out-performance line
consensu oper margin slightli street
break-even forecast adj ebitda higher ep compar
favor consensu pleas see exhibit
guidanc prior
oper margin expect prior adj ebitda
prior revenu forecast top end guidanc
adj ebitda estim slightli due better oper leverag
pleas see exhibit summari estim chang
extend discuss dxcm posit competit
landscap recent check pleas see recent diabet primer
extend discuss profit ramp prospect
convict compani margin expans stori pleas see
note follow dec analyst day
price target increas appli slightli higher ev/sal
multipl premium group higher forecast
arriv price target wed note forecast factor
revenu japan estimate commerci increment market
opportun broader adopt market innov
measur analyt outer year also repres potenti
upsid forecast
chang made note
buy chang
page analyst certif
perform rel
inc design commerci
platform use peopl
profit loss summari
growth margin
continu glucos monitor cgm devic use
diabet patient monitor glycem level view
compani technolog best-in-class type platform vs
competit offer abbott
manag work secur greater patient access
pharmaci channel believ price
differenti cgm self-monitor blood glucos test
smbg use finger stick draw blood test blood sugar
set narrow potenti drive greater adopt
 see pathway mid-teen oper margin
synchron manag target
provid dec analyst day entri new channel mix
shift pharmaci dme ramp penetr
medicar market creat volum opportun help
price target base ev/revenu
billion sale growth toward high end
med-tech believ deserv premium multipl vs peer
note sale estim includ contribut
pipelin verili addit end market japan
chang net debt
average cost debt
risk invest thesi
thesi price target could risk compani unabl
drive adopt cgm technolog level
could occur diabet patient clinician believ
technolog better easier use compani unabl
drive sensor price level make afford
well manag unabl drive leverag profit
forecast could risk
exhibit varianc estim
varianc estim
varianc estim
varianc estim
varianc estim
estimate
estimate
estimate
estimate
inc revenue servic freight accessori etc
sale
sale
expect deliv upsid growth
model high teen patient captur type diabet
market see signific increment revenu potenti market opportun type
margin softwar subscript repres addit wedg
address market current contempl forecast given
upsid potenti believ stock deserv valu ev/sal multipl
premium vs peer price target prior assum multipl prior
sale compar peer comp set median revenu
growth rate includ intuit surgic align technolog
system intersect ent believ could upsid potenti number
compani begin commerci verili type non-intens insulin
initi -- current factor revenu program
thesi price target could risk compani unabl drive adopt
cgm technolog level model could occur diabet patient
clinician believ technolog better easier use compani
unabl drive sensor price level make afford widespread
adopt well manag unabl drive leverag profit forecast
could risk
profit loss account
sale
inco oper
inco oper
inco oper
inco oper
incom equiti invest
net incom provis incom tax
provis incom tax
inco oper
inco oper
inco oper
inco oper
sharecount dilut q/q quarter y/i annual
cash equival
short-term market securit avail sale
prepaid current asset
properti plant equip net
current portion long-term debt
account payabl accru liabil
accru payrol relat expens
current portion defer revenu
oper leas liabil net current portion
prefer stock par share author none issu outstand
treasuri stock cost
total liabil stockhold equiti
total liabil stockhold equiti
total liabil stockhold equiti
total liabil stockhold equiti
oper
oper
oper
oper
depreci amort
non-cash issuanc common stock
impair intang asset
chang asset liabil net effect acquisit
prepaid expens asset
account payabl accru liabil
accru payrol relat expens
defer rent liabil
total chang work capit
net cash oper
net cash oper
net cash oper
net cash oper
invest
invest
invest
invest
purchas market secur
proce matur market secur
purchas equiti invest
purchas pp
acquisit net cash acquir
net cash invest
net cash invest
net cash invest
net cash invest
financ
financ
financ
financ
net proce issuanc common stock
repurchas treasuri stock
payment acquisit relat conting consider liabil
proce issuanc convert debt net issuanc cost
proce sale warrant
purchas convert note hedg
proce short-term borrow
repay short-term borrow
repay long-term debt
net cash financ
net cash financ
net cash financ
net cash financ
net chang cash equival
net chang cash equival
net chang cash equival
net chang cash equival
 begin period
 end period
